Document is current
Any future updates will be listed below
-
Authors
Gallego-Paüls, Marta
Hernández-Ferrer, Carles
Bustamante, Mariona
Basagaña, Xavier
Barrera-Gómez, Jose
Lau, Chung-Ho E.
Siskos, Alexandros P.
Vives-Usano, Marta
Ruiz-Arenas, Carlos
Wright, John
Slama, Remy
Heude, Barbara
Casas, Maribel
Grazuleviciene, Regina
Chatzi, Leda
Borràs, Eva
Sabidó, Eduard
Carracedo, Ángel
Estivill, Xavier
Urquiza, Jose
Coen, Muireann
Keun, Hector C.
González, Juan R.
Vrijheid, Martine
Maitre, Léa http://orcid.org/0000-0003-3682-7117
-
Funding
Funding for this research was provided by:
H2020 Health (874583)
- License Information
-
More Information
Article History
Received: 30 March 2021
Accepted: 8 June 2021
First Online: 22 July 2021
Declarations
:
: Local ethical committees approved the studies that were conducted according to the guidelines laid down in the Declaration of Helsinki. The ethical committees for each cohort were the following: BIB: Bradford Teaching Hospitals NHS Foundation Trust, EDEN: Agence nationale de sécurité du médicament et des produits de santé, INMA: Comité Ético de Inverticación Clínica Parc de Salut MAR, KANC: LIETUVOS BIOETIKOS KOMITETAS, MoBa: Regional komité for medisinsk og helsefaglig forskningsetikk, Rhea: Ethical committee of the general university hospital of Heraklion, Crete. Informed consent was obtained from a parent and/or legal guardian of all participants in the study.
: Not applicable.
: The authors declare that they have no competing interests. MC is currently affiliated to AstraZeneca but the company had no role in the design, conduct, or analysis of the H2020-EU funded project.
